BATM Advanced Communications Ltd. (LON:BVC)
London · Delayed Price · Currency is GBP · Price in GBX 15.60
-0.15 (-0.95%)
Mar 5, 2026, 4:37 PM GMT
LON:BVC Market Cap
LON:BVC has a market cap or net worth of 53.56 million as of March 5, 2026. Its market cap has decreased by -32.21% in one year.
Market Cap
53.56M
Enterprise Value
39.51M
Revenue
86.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.60
Market Cap Chart
Since March 30, 1998, LON:BVC's market cap has increased from 47.21M to 53.56M, an increase of 13.47%. That is a compound annual growth rate of 0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 53.56M | -23.97% |
| Dec 31, 2025 | 70.45M | -12.53% |
| Dec 31, 2024 | 80.54M | -8.79% |
| Dec 29, 2023 | 88.30M | -26.09% |
| Dec 30, 2022 | 119.47M | -67.74% |
| Dec 31, 2021 | 370.41M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.01B |
| GSK plc | 84.79B |
| Haleon | 34.46B |
| Smith & Nephew | 11.35B |
| ECO Animal Health Group | 67.76M |
| Faron Pharmaceuticals Oy | 67.15M |
| Hemogenyx Pharmaceuticals | 60.33M |
| Creo Medical Group | 56.85M |